LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 80.88 | 17.25 | 14 | 5826 | 0.0024 | -0.0246 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 80.88 | 17.25 | 1160 | 5826 | 0.1991 | 0.6504 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 82.85 | 17.25 | 426 | 5861 | 0.0727 | 0.4643 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 82.85 | 17.25 | 1095 | 5861 | 0.1868 | 0.6382 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 82.85 | 17.25 | 17 | 5861 | 0.0029 | -0.0017 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 82.85 | 17.25 | 1182 | 5861 | 0.2017 | 0.6532 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 84.82 | 17.25 | 434 | 5924 | 0.0733 | 0.4665 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 84.82 | 17.25 | 1125 | 5924 | 0.1899 | 0.6420 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 84.82 | 17.25 | 13 | 5924 | 0.0022 | -0.0330 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 84.82 | 17.25 | 1170 | 5924 | 0.1975 | 0.6497 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 86.79 | 17.25 | 394 | 6008 | 0.0656 | 0.4484 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 86.79 | 17.25 | 1068 | 6008 | 0.1778 | 0.6300 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 86.79 | 17.25 | 4 | 6008 | 0.0007 | -0.1589 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 86.79 | 17.25 | 1165 | 6008 | 0.1939 | 0.6469 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 88.76 | 17.25 | 493 | 6047 | 0.0815 | 0.4868 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 88.76 | 17.25 | 1111 | 6047 | 0.1837 | 0.6367 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 88.76 | 17.25 | 8 | 6047 | 0.0013 | -0.0869 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 88.76 | 17.25 | 1151 | 6047 | 0.1903 | 0.6436 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 90.74 | 17.25 | 543 | 6109 | 0.0889 | 0.5028 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 90.74 | 17.25 | 1096 | 6109 | 0.1794 | 0.6327 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 90.74 | 17.25 | 13 | 6109 | 0.0021 | -0.0329 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 90.74 | 17.25 | 1177 | 6109 | 0.1927 | 0.6465 | MN20160310_N02 | G17 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 92.71 | 17.25 | 612 | 6184 | 0.0990 | 0.5228 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 92.71 | 17.25 | 1081 | 6184 | 0.1748 | 0.6284 | MN20160310_N02 | C13 |
| MCF 10A-H2B-mCherry | Palbociclib | 10 | 92.71 | 17.25 | 6 | 6184 | 0.0010 | -0.1170 | MN20160310_N02 | G17 |